To observe the improvement of Chalder scale score in patients with chronic fatigue syndrome treated by Compound Ciwujia Granules. Improvement =\[(baseline score - post-treatment score)/baseline score\]\*100%
Who can participate
Age range18 Years – 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Meet the diagnostic criteria of Western medicine for chronic fatigue syndrome;
* Meet the diagnostic criteria of spleen and kidney deficiency syndrome or heart and spleen deficiency syndrome of traditional Chinese medicine;
* Chalder scale score greater than 12 points;
* Age 18-70 years old, gender is not limited;
* Agree to participate in this clinical study, voluntarily sign informed consent, and agree to participate in visits, examinations, and treatments according to the requirements of the research protocol.
Exclusion Criteria:
* Combined with mental disorders such as severe anxiety and severe depression;
* Secondary fatigue caused by drugs or other reasons;
* Patients with serious primary diseases such as cardiovascular and cerebrovascular, liver, kidney and hematopoietic system, malignant tumors, and other serious complications; Abnormal liver and kidney function ALT, AST≥ 1.5 times the upper limit of normal value, Cr \> the upper limit of normal value;
* Women who are pregnant, breastfeeding or who may become pregnant in the study and cannot use effective contraception;
* Have received relevant treatment and may affect the observed effect indicators;
* Suspected to have a history of drug abuse or other patients who do not meet the eligibility criteria;
* Allergic physique and allergic to the drug;
* Uncontrolled hypertension (DBP \> 100mmHg or SBP \> 160 mmHg);
* Diabetic patients;
* Those that the researcher thinks are not suitable for partic…
What they're measuring
1
The subjects' Chalder scale scores changed after 3 and 6 weeks of treatment
Timeframe: Screening/Baseline period (Week -2 to Day 0), Treatment period (Week 3 ± 5 days), Treatment period (Week 6 ± 5 days)